A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Abstract Background This meta-analysis evaluated the effectiveness and safety of dexamethasone (DEX) implant and intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular edema (DME). Methods The PubMed, Embase, clinicaltrials.gov website and Cochrane Library databas...
Main Authors: | Ye He, Xin-jun Ren, Bo-jie Hu, Wai-Ching Lam, Xiao-rong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-018-0779-1 |
Similar Items
-
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01) -
Intravitreal dexamethasone implants for diabetic macular edema
by: Alicia Pareja-Ríos, et al.
Published: (2018-01-01) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2020-10-01) -
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01) -
Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy
by: Chakraborty S, et al.
Published: (2024-01-01)